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Appropriate strategy for immunisation of children in India 
IV : Measles and its control, priority number one 
Mark C. Sleinhoff, M.D., F.A.A.P. and T. Jacob John, F.R.C.P., F.A.A.P., PhD. 
Although a hidden health problem, measles is the commonest vaccine- 
preventable disease and the most common preventable cause of death 
among our underfives. These facts, plus the availability of a safe and 
effective vaccine make measles vaccinationthe ighe>t priority in the 
control of communicable disease in India. The use of the pulse vaccina- 
tion strategy will result in better coverage rates than the conventional stra- 
tegy of immunisation i fixed health centres. India's annual requirement 
of measles vaccine is 20 million doses. For economy and uninterrupted 
supply, measles vaccine must be manufactured in India without any 
further delay. 
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In our review of the priorities of vac- 
cines in the Indian context, we suggested 
that the highest priority should be given 
to measles vaccine3 Although measles 
immunisation has been an integral com- 
ponent of routine childhood immunisation 
in most developed countries for nearly two 
decades, it is not yet part of our national 
programme of immunisation in that the 
vaccine is not procured and distributed 
by governmental agencies. An expert 
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study group, reporting recently on an 
alternative strategy for health for all, 
listed 10 communicable diseases to be 
controlled or eradicated in India by the 
year 2000, but measles was not included." 
This state of affairs may be partly due to 
the failure of many experts to perceive 
the public health importance of measles, 
which remains hidden because popular 
beliefs prohibit seeking medical attention 
for this disease a'4. Since only a very small 
proportion of children with measles are 
brought to clinics or hospitals, most 
physicians have not been aware of the 
high frequency of this illness or the magni- 
tude of its effects. We will review infor- 
mation from several community studies 
in India to show that measles is the most 
common vaccine-preventable illness, as well 
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as the most common vaccine-preventable 
cause of death in pre-sehool children. 
The Indian Academy of Pediatrics 
accepted the recommendations of early 
investigators and included measles vaccine 
in their routine immunisation schedule.~-7 
Subsequently, measles vaccine has been 
included in the list of vaccines under the 
Expanded Programme of Immunisation 
(EPI), but no steps have been taken to 
make it available for general use in the 
community. This may be due to the belief 
that the vaccine is too expensive and has 
too stringent cold storage requirements to 
be included in a national programme. In 
contrast, we believe that measles immuni- 
sation is a simple and relatively cheap 
public health measure for improving 
health and reducing mortality of children 
in India. We will discuss below why 
measles hould be controlled and a stra- 
tegy by which this may be achieved. 
Epidemiology 
The epidemiology of measles in India 
has been delineated by investigations of
outbreaks, retrospective and longitudinal 
studies and serological surveys, -zz These 
studies how that virtually all children are 
infected during childhood and a large 
majority develop clinical measles. In 
rural areas measles tends to occur as 
periodic epidemics every 2,3 or 4 years, 
whereas in urban areas manual outbreaks 
may oecurla'J% Epidemics usually occur 
in the cooler months of the year in most 
parts of India. ~ 
During outbreaks the highest attack 
rate (upto 50%) is seen in 1 to 3 years 
old, while younger and older children 
are less often affected. In most outbreaks 
10-15% of all cases occur in infants under 
12 months s-~~ although in one retrospec- 
tive survey in rural Maharashtra, nearly 
30% of all cases were reported in 
infantsY 
Seroepidemiological investigations have 
been reportecl from Bombay, VeUore, 
Chandigarh, Delhi and PondicherryJ 8-zz 
The data from Vellore and Bombay are 
displayed in Figure 1 to show the range 
of these results. The survey results of 
Vellore, Chandigarh, Pondicherry and 
Delhi, a retrospective study in Maharash- 
tra ~z and prospective surveillance in 
Delhi 17 all show a median age of measles 
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Fig. 1 : The percentage of children with measles 
antibody inVeUore (HAI>8), and Bombay 
(HAI>I0) (Adapted from Ref. 19 and 18) 
infection between 12 and 24 months. The 
serological study in Bombay demonstra- 
ted a higher median age of infection, 
namely 48 months, is
Among the vaccine preventaUe dis- 
eases of importance in India, measles 
appears to be the one with the highest 
overall attack rate, with whooping cough 
as a close second 2a. Although polio- 
viruses ~-4 and Corynebacterium diphtheriae 
may also infect virtually all children, 
diseases due to them are much less 
frequent. Measles is the single most corn- 
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mon vaccine-preventable disease of child- 
hood in our country. 
Since only a small proportion of 
measles cases are admitted to hospital, we 
will not review the data from hospital 
studies. As stated earlier there are several 
community-based studies on the epidemio- 
logy, sequelae and mortality of measles, -29 
Selected ata from Vellore area, derived 
from studies of outbreaks in 7 villages 
with a total of 1198 Pre-school children, s'9 
are presented in Table 1. Attention is 
drawn particularly to the case-fatality rat- 
es of 3 to 16 per cents. Reports from other 
parts of India also show that about 30 per 
Table 1 : Measles Epidemics Near Vellore 
Attack rate : 20-40~ of the unimmuni- 
zed children became ill 
Complications : of those who were ill : 
14-50~ developed iarrhoea 
7-50~ developed severe 
respiratory disease 
87% Lost weight 
3-16~ died 
Case fatality rate : 
Measles mortality 
rate :" 0.7-4.2~ ofunimmunized 
preschool children died of 
measles 
An important sequela of measles is the 
weight loss which occurs in a majority of 
cases. Most children take two months or 
more to regain the lost we~ht s'lS. In 
some children the weight loss leads to 
gross protein-energy malnutrition and its 
complications. Other long-term consequ- 
ences include the activation of tuberculosis, 
the development of bronchiectasis, and the 
rare instances of subacute sclerosing 
panencephalitis. These sequelae may lead 
to death at a time remote from the meas- 
les episode and may not be recognised as 
m ea~les-related by the family or the physi- 
cian. Such late deaths are not included 
either in calculating the ease fatality rates 
mentioned earlier or in estimating 
mortality figures. 
The proportions of deaths caused by 
measles as reported in a national survey 
of causes of death and in longitudinal 
surveillance in rural areas in Tamil Nadu 
and Punjab are presented in Table 2 
a4,16,ts. Using the all-India data, approx- 
imately two per cent of infant deaths and 
about 10 percent of pre-school deaths are 
caused by measles, which is thus the third 
most frequent cause of death in under. 
fives, &~probably, the most common cause 
of vaccine-preventable d ath in Indian 
childrenY5 The Tamil Nadu data also 
cent of affected children develop serious 
complications and that the case fatality 
rate is 1-3 per cent. s-17 In general, the 
case fatality rate is low in communities 
with adequate nutrition and health care, 
but it may reach 20 per cent in rural com- 
munities without ready access to medical 
care.9,~0, lz In one epidemic, measles 
killed 9% of all the children under 2 in the 
Village. 9 
Table 2 : Proportion of All Deaths 
Caused by Measles 
Region Under 1-4 
1 year years 
All India - -  19792~ 1.9~ 9.4~ 
Tamil Nadu- -  19721~ 2.3~ 10.3~ 
Punjab - -  195914 3.6~ 8.3~ 
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shows measles to be the most common 
vaccine-preventable cause of death. In the 
Punjab study, tetanus was the most com- 
mon account of the high incidence of neo- 
natal tetanus. Although respiratory and 
diarrhoeal diseases are the most common 
causes of death, they are multifactorial in 
aetiology and are not preventable by 
vaccines available today. Using the figures 
in Table 2 and current estimaters of the 
child population and childhood mortality 
rates in India, it can be conservatively 
estimated that measles kills over 200,000 
children under five, annually. In other 
words, of the more than 20 millions in- 
fants born each year, one in 100 will die 
of measles before age five. This estimate 
of the measles mortality rate is similar to 
the rate published 20 years ago. 5 In the 
intervening years the estimated annual 
measles mortality has increased from 
85,000 to 200,000 due to population grow- 
th without a measles immunisationpro- 
gramme. 
Vol. 49, No. 398 
The above data shows that measles 
is a serious public health problem in 
India. Fortunately it is a problem for 
which a solution is readily available, 
namely measles vaccine, which has been 
proven both safe and effective. 
Measles Vaccine and Seroconversion 
The live attenuated measles virus 
vaccine has been in use in many parts 
of the world for two decades, and has 
a very high protective efficacy. "6 Table 
3 displays seroconversion rates in 
American, Kenyan and Indian children 
and the protective efficacy rates in 
American children 27-sl. It is evident that 
seroconversion (development of antibo- 
dies) and effeacy (protection from disease 
when exposed) are related to the 
age of the child at vaccination. 
This is because maternal antibodies in 
the infant prevent infection and serocon- 
version, zz These antibodies are catabo- 
Table 3 : Seroconversion a d efficacy rates of measles vaccination 
Age at 
Vaccination 
(Months) 
Seroconversion 
US Kenya India 
~o Efficacy 
US 
6 32 
7 58* 
8 71- 
9 72 
10 85 
11 95 
12 95 
13 96 
14 95 
15 93 
16 100 
43 
93* 
90 
100 
85 
I 
1 56 
64 
91 
94 
95 
* Difference significant by x ~, P.~0.01. 
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lised at a steady rate: therefore, as age 
increases the maternal antibody level 
declines and the likehood of seroconver- 
sion increases. In American children both 
seroconversion and efficacy rates are 
greater than 90 per cent when they are 
vaccinated at 12 months, and these rates 
exceed 95 per cent if vaccination is at 
14-15 months. It appears that Kenyan 
children may seroconvert earlier as their 
seroconversion rate is over 90 per cent 
at 7 months 2s Indian children seem to fall 
between American and K enyan children in 
their age specific seroconversion rates. 
Other studies in Indian children have 
reported discordant results. Two groups 
have reported 60-70 per cent seroconver- 
sion rates in infants of 6-12 months. ~'a3 
A recent study showed 85 per cent sero- 
conversion in infants over 10 months, a4 
One well-conducted study reports a rate 
of 95 per cent seroconversion in children 
aged 6 to 18 months, but no age-specific 
rates were given, a5 An investigation of 
an outbreak of measles in villages near 
Vellore demonstrated 100 per cent pro- 
tective fficacy of the vaccine when given 
to children at or after 12 months of age. 9 
In short, the seroconversion rates and 
proctective efficacy are very high in 
Indian children given measles vaccine at 
12 months or later. Further studies are 
awaited to define age specific serocon- 
version rates at earlier ages. The princi- 
ples for successful vaccination against 
measles are, 1) Vaccinate before the age 
of occurrence of the disease 2) Vaccinate 
at ages when seroconversion a d efficacy 
are high 3) Vaccinate as high a propor- 
tion of susceptible as possible 
Age of Vaccination 
There has been discussion regarding 
the optimum age for measles immunisa- 
tion in India 6,7,34. The first principle 
above a~gues for early immunisation, 
perhaps at six months. The second prin- 
ciple indicates immunisation at an older 
age, say fifteen months. A balance must 
be struck between these two optima. 
One approach is to use estimates of 
age-specific ncidence and seroconversion 
rates and to calculate the number of 
measles cases prevented by immunisation 
at specified ages. This has been done in 
Table 4, using the serological data from 
Table 4 : Reduction of measles cases by vaccination at various ages 
Age Estimated % Estimated % Estimated 
previously seroconver- Measles cases 
infected sion prevented* 
6 months 1-3 30-50 29-50 
9 months 4-9 70-90 64-86 
12 months 10.40 95-100 57-90 
15 months 15-50 100 50-85 
*100--(Yo previously infected) • ~ seroconversion I00  - = % Cases prevented. 
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figure 1 to estimate incidence rates and 
assuming that Indian children will sero- 
convert at rates between those of Kenyan 
and US children. Note that immunisa- 
tion between 9 and 12 months of age 
will prevent the greatest number of cases. 
This supports the recommendations of 
the Indian Academy of Pediatrics and 
the Ministry of Health and Family Wel- 
fareT. The table shows that the optimal 
age of immunisation depends on the 
local pattern of disease. During epide- 
mics and in communities with a high 
proportion of cases before 1 year of age, 
9 months is the best age for immunisa- 
tion. Vaccination at the first birthday 
or later is more appropriate for inter- 
epidemic periods and for communities 
with few cases before 1 year. An effective 
immunisation progrom will likely shift 
the median age of infection upwards, and 
the optimal age for immunisation could 
also be moved upwards to take advantage 
of the higher serocouversion rate. 
Strategy of Immunisation 
The means of obtaining as high an 
immunisation coverage rate as possible is 
the strategy discussed here. If a high pro- 
portion of susceptibles are vaccinated: the 
number of susceptibles remaining will be 
too low to sustain transmission within the 
community, and the periodio epidemics of 
measles hould not occur. 
Two strategies for measles immunisat- 
ion have deen described. Conventional 
imrnunisation of children in clinics as they 
reach the recommended age is the first 
strategy. It requires that highly motivated 
and well-informed parents bring their 
children for immunization at the correct 
lime, and that clinics have a constant 
supply of properly stored vaccine. This 
strategy has not been successful in achiev- 
ing high coverage rates with DPT or OPV 
in India. Even if all children attaining 
the optimal age are vaccinated in clinics, 
this technique will reduce susceptibles 
relatively slowly and lead to the interrupt- 
ion of epidemics only after a few years. 
We have suggested an alternative 
trategy, the annual immunization of child- 
ren near their homes by mobile teams 3e. 
We feel this pulse immunisation is better 
suited to our conditions. Because vaccine 
is brought o neighbourhoods after publi- 
city, parental motivation is less important. 
The difficulty of cold chain management 
is reduced since there are fewer steps bet- 
ween producer and the child. The first 
immunisation pulse should include alJ 
children under five who have not had 
measles. Assuming a high coverage during 
this initial pulse, the eqidemic pattern 
will be interrupted. After this first pules, 
annual immunisation of children over one 
year will immunise new susceptibles. The 
availability of central vaccine storage 
and mobile teams allow quick intervention 
to stop measles epidemics if they develop. 
Other advantages in the utilization of 
resources and in the further development 
of primary health care delivery have been 
discussed 3e. 
Conclasions and Recommendations 
As a means to reduce the mortality 
and improve the health and nutrition of 
our children, measles immunisation should 
become a part of the national immunisa- 
tion programme, and receive the highest 
priority. The pulse immunisation strategy 
is better suited to India than the conven- 
tional strategy of year-round, clinic based 
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immunisation. As India's requirement o f  
measles vaccine will be over 20 mill ion 
doses annually, it must be manufactured 
within the country as a priority in the 
control of  communicable diseases. As 
the nation with the third largest group of  
scientists and technicians and with the 
presetxt state of  rapid advances in techno- 
logy, India should achieve this with no 
further loss of  time. 
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